Zoetis Inc.
Zoetis Inc. (ZTS) Stock News
The latest ZTS headlines and market coverage — 5 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
ZTS INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Robbins Geller announces a class action lawsuit against Zoetis Inc. for alleged securities violations. The lawsuit claims Zoetis made false statements about its flagship products including Librela, Simparica Trio, Apoquel, and Cytopoint, failing to disclose weakening demand, market share losses to competitors, and increased competitive pressures. Investors who purchased ZTS securities between January 14, 2025 and May 6, 2026 can seek appointment as lead plaintiff by July 27, 2026.
- GlobeNewswire Inc.·
ZTS Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Zoetis Inc. Class Acton Lawsuit
Robbins LLP is reminding investors of the July 27, 2026 lead plaintiff deadline in a class action lawsuit against Zoetis Inc. The lawsuit alleges that Zoetis misled investors about declining sales of flagship products including Librela, Simparica Trio, Apoquel, and Cytopoint due to FDA safety warnings, market competition, and market share losses. The company's stock fell 21.5% following disappointing Q1 2026 results and reduced full-year guidance.
- GlobeNewswire Inc.·
ZTS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
A class action lawsuit has been filed against Zoetis Inc. alleging the company made false statements about its flagship companion animal products. The lawsuit claims Zoetis failed to disclose weakening demand for Librela, market share losses in Simparica Trio and dermatology products to competitors, and increased competitive pressures. Stock prices fell significantly following quarterly earnings announcements in August 2025 (4%), November 2025 (14%), and May 2026 (21%).
- GlobeNewswire Inc.·
ZOETIS INC. (ZTS) INVESTOR ALERT Investors With Large Losses in Zoetis Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
Bernstein Liebhard LLP has announced shareholder class action lawsuits against three companies: Zoetis Inc. for alleged materially false and misleading statements regarding business operations and financial stability during January 2025-May 2026; Calix, Inc. for the period January-April 2026; and AeroVironment, Inc. for June 2025-March 2026. Investors who suffered losses are encouraged to contact the firm or file to become lead plaintiffs by specified deadlines.
- GlobeNewswire Inc.·
Levi & Korsinsky Announces Investigation of Securities Claims Against Zoetis (ZTS)
Zoetis Inc. (NYSE: ZTS) shares fell approximately 21.5% on May 7, 2026, after the company slashed its full-year revenue guidance, citing weaker U.S. pet-care demand, macroeconomic pressure, and heightened competition. The guidance cut came less than three months after management had guided to 3-5% organic operational revenue growth. Levi & Korsinsky is investigating whether the company and its executives made materially misleading statements regarding revenue outlook and competitive positioning.